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Abstract
Background Medical treatments for irritable bowel syn-
drome (IBS) are often disappointing. A colonic irrigation
system, the Ashong colonic irrigation apparatus (ACIA),
was designed as a patient-administered device for defeca-
tion disorders. This pilot study evaluated the efficacy and
safety of ACIA for IBS.
Methods Eighteen patients, 12 with constipation-dominant
IBS (IBS-C) and 6 with diarrhea-dominant IBS (IBS-D)
group, were studied. Patients were randomized into treat-
ments of 1–4 weeks. Colonic irrigation was performed
twice daily for 6 consecutive days per week. To determine
the response to treatment, bowel movement frequency,
stool consistency, abdominal pain, patient satisfaction with
bowel movements, and distress/discomfort due to symp-
toms were assessed.
Results The scores of abdominal pain (p\ 0.001), satis-
faction (p\ 0.001), and distress/discomfort (p\ 0.001)
improved significantly. The frequency of bowel move-
ments in the IBS-C group increased from 1.68 to 3.78 times
per week (p\ 0.001). The occurrence of Bristol Stool
Scale type 1 and 2 stool passage decreased from 45 to 13 %
(p = 0.009) in the IBS-C group and type 6 and 7 stools
decreased from 62 to 28 % (p = 0.005) in the IBS-D
group. Only mild adverse events occurred, and all patients
completed treatment.
Conclusions Colonic irrigation with ACIA is safe and can
improve abdominal pain, constipation, and diarrhea asso-
ciated with IBS. Patients were more satisfied with their
bowel movements and found their symptoms were less
disturbing. Larger studies on long-term efficacy and quality
of life and on placebo effects are needed.
Keywords Ashong colonic irrigation apparatus  Colonic
irrigation  Irritable bowel syndrome
Introduction
Irritable bowel syndrome (IBS) is a functional gastroin-
testinal disorder according to the Rome III classification
[1]. IBS affects 10–20 % of the population, predominantly
females. The pathogenesis of IBS involves abnormalities in
motility, visceral sensation, brain–gut interaction, and
psychosocial distress. More recently, altered gut immune
activation, intestinal permeability, and the intestinal and
colonic microbiome have been shown to contribute to IBS.
Treatment of IBS includes psychological support, exer-
cises, diet management, and medical treatments. The
symptoms of constipation-dominant IBS (IBS-C) may be
improved by fiber supplements, laxatives, and avoidance of
short-chain carbohydrates and gluten. Anti-diarrheal med-
ications, 5-HT3 antagonists, antispasmodics, and antide-
pressants are also effective [2]. A recent meta-analysis
showed that administration of probiotics also improved
symptoms and quality of life (QoL) for patients with IBS
[3].
Rectal or colonic irrigation has been shown to be suc-
cessful in treating neurogenic, congenital, and idiopathic
bowel dysfunction; constipation; and fecal incontinence, as
well as improving QoL [4–10]. Patients with fecal
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incontinence after low anterior resection may also benefit
from colonic irrigation [11]. Medical treatments are often
temporary and disappointing. The role of colonic irrigation
for IBS, however, is not yet well established.
The Ashong colonic irrigation apparatus (ACIA) is a
colonic irrigation system approved by the Taiwan Food and
Drug Administration. It is a simple device designed for
patient self-administration. The device is composed of a
water tank, filter system, and an L-shaped disposable soft
silicone rectal tube affixed to the toilet (Fig. 1). The water
flow rate is maintained at 5 mL per second with a constant
water temperature of 36 ± 2 C. The duration of water
flow can be adjusted as required. After sitting properly on
the toilet and inserting the rectal tube, patient manipulates
the ACIA via a remote control. The aim of this pilot study




This clinical trial was approved by the Institutional Review
Board of Mackay Memorial Hospital. Male and female IBS
patients between 20 and 65 years of age who were
refractory to previous medicinal treatments were invited
for primary screening. Informed consent was obtained from
all patients before the screening phase. Exclusion criteria
included hernia, inflammatory bowel disease, grade 3 and 4
hemorrhoids, anal fissure, rectal prolapse, megacolon,
peptic ulcer disease, previous abdominal surgery, renal
impairment, uncontrolled hypertension, pregnancy, paral-
ysis, and aortic aneurysm. All patients were assessed by
double-contrast barium enema or colonoscopy to exclude
any organic colonic lesions. Only those who met the Rome
III diagnostic criteria of diarrhea-dominant IBS (IBS-D)
and IBS-C [1] were included in the study.
Treatment strategy
ACIA was used with a constant water temperature of
37 C, water flow at 5 mL/s for 100 s. Colonic irrigation
was repeated for 8 cycles to constitute one complete ther-
apeutic section. Patients were allowed to defecate at any
time while irrigation was in progress.
Treatments were divided into 1-, 2-, 3- and 4-week
courses for IBS-C (subgroups: 1C, 2C, 3C, 4C) and IBS-D
(subgroups: 1D, 2D, 3D, 4D) groups in order to evaluate
the influence of treatment duration on efficacy. Patients
were randomized consecutively, beginning with the 4-week
course and continuing through the 1-week course, into each
of the 8 treatment subgroups with the aim of producing 8
groups of 3 patients each. Patients received colonic irri-
gation twice daily for 6 consecutive days per week and
were allowed to withdraw from the study at any time. A
study nurse stayed beside the patients during irrigation,
giving instructions, recording adverse effects, and
Fig. 1 a Overall view of the
Ashong colonic irrigation
apparatus. Tap water in the
water tank flows through the
filter system, then passes
through the rubber tube, and
finally reaches the rectal tube.
b The rectal tube is fixed to the
toilet. Filtered water flows out
of the tip of the rectal tube in
four directions, and the flow rate
is maintained at 5 mL/s.
c Diagram showing the method
of rectal tube insertion
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monitoring safety. After receiving a thorough explanation
of the irrigation system, patients were instructed to
manipulate the device themselves throughout the study
period.
Patient diary
Patients maintained a record of bowel movement (BM)
frequency, stool consistency, and abdominal pain intensity,
from 7 days before treatment (pre-treatment phase) to
7 days following treatment (post-treatment phase). Stool
consistency was recorded according to Bristol Stool Scale
(BSS) (types 1–7) [12]. The scores of abdominal pain,
satisfaction with BM, and distress/discomfort due to
symptoms were recorded on a 0-to-10 rating scale. A score
of 10 indicated the most severe abdominal pain, greatest
satisfaction with BM, and least distress/discomfort due to
symptoms.
Evaluation of efficacy and safety
Efficacy was evaluated by measuring treatment-related
changes in BM frequency, stool consistency, abdominal
pain, satisfaction with BM, and distress/discomfort due to
symptoms. All adverse events occurring in the course of
the study period were recorded. A mild adverse event was
defined as any mild symptom requiring neither medical
intervention nor discontinuation of treatment. A moderate
adverse event was defined as any intolerable symptom
requiring medical intervention and terminating irrigation.
A severe adverse event was defined as any life endangering
event requiring immediate medical intervention. Patients
were provided 24-h access to telephone assistance. Blood
serum samples were obtained prior to treatment and 2 days
(±1 day) before the end of treatment for analysis of glu-
tamic-oxaloacetate transaminase (GOT), glutamic-pyruvic
transaminase (GPT), gamma-glutamyl transpeptidase
(cGT), alkaline phosphatase (ALKP), Na1, K1, Cl-, and
blood urea nitrogen (BUN).
Statistical analysis
Demographic data and clinical characteristics were
expressed as proportions for categorical variables and as
mean ± standard deviation (SD) values for continuous
variables. The paired t test or Wilcoxon signed-rank test
was used to compare pre- and post-treatment changes in
scores of abdominal pain, satisfaction with BM, and dis-
tress/discomfort due to symptoms. To assess the pre- and
post-treatment changes in BM frequency and stool con-
sistency, participants were enrolled in IBS-C and IBS-D
subgroups. Differences between each of the variables were
assessed using the two-tailed paired t test or v2 test, and
values of p\ 0.05 were considered statistically significant.
Analyses were carried out using SAS, version 9.0 (SAS,
Cary, NC, USA).
Results
Between December 18, 2013, and July 18, 2014, 23
patients participated in the initial screening, and only 18
patients fulfilled the diagnostic criteria. One withdrew from
the ongoing study, and 1 was excluded due to a diagnosis
of cervical cancer. Two additional individuals were
screened as potential substitutes for the missing 2 within
the same study period, but unfortunately, only 6 patients
were enrolled in the IBS-D group. Eighteen patients (13
females; mean age 45.2 (24–62) years) completed the
treatments and entered the final analysis (Fig. 2). The IBS-
C group was female dominant, whereas the IBS-D group
was male dominant (Table 1).
Overall abdominal pain score decreased significantly
from 4.23 to 0.73 (p\ 0.001) after colonic irrigation
treatment. The score of satisfaction with BM increased
from 3.10 to 6.52 (p\ 0.001), and the score of distress/
discomfort due to symptoms improved from 2.95 to 6.75
(p\ 0,001) (Fig. 3a). In addition, the results of the 2
individual groups showed significant improvements. After
ACIA treatment, all patients in the IBS-D group and 5 of
12 patients in the IBS-C group experienced complete relief
from abdominal pain.
BM frequency in the IBS-C group increased from 1.68
to 3.78 times per week (p\ 0.001; Fig. 3b), and the per-
centage of BSS type 1 and 2 stool passage decreased from
45 to 13 % (p = 0.009; Fig. 3c) after treatment. Only 1
patient in the 1C subgroup showed no improvement in BM
frequency, but still showed an improvement in stool con-
sistency from BSS type 1 to type 4. Even though there was
no significant improvement in BM frequency in the IBS-D
group (Fig. 3b), the percentage of BSS type 6 and 7 stool
passage decreased significantly from 62 to 28 %
(p = 0.005; Fig. 3c) after colonic irrigation. The only
patient in the 1D subgroup showed persistent passage of
loose stools, and this was the only patient from the IBS-D
group showing no improvement in stool consistency.
One-third of patients experienced mild adverse events
with neither discontinuation of treatment nor medical
intervention. Abdominal cramping pain occurred in 2
patients (11.1 %), 4 (22.2 %) suffered from a sensation of
mild abdominal fullness, 1 patient (5.56 %) experienced
general weakness, and 1 presented with anal pain (5.56 %).
Only 2 patients suffered from more than one adverse event.
Serum levels for the electrolytes Na1, K1, Cl2, before
and after treatment, were all within normal ranges. Lower
than normal limits of serum GPT, GOT, cGT, and BUN
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levels were observed before treatment in 8 participants
(44.4 %). One male who was a heavy drinker had elevated
basal and post-treatment levels of GOT and GPT.
Discussion
The beneficial effect of colonic or rectal irrigation on
neurogenic or congenital defecation disorders is well
known, and functional constipation and diarrhea have also
been shown to benefit from rectal irrigation [13]. Even
though the exact mechanism underlying the response of
IBS to colonic irrigation is not known, our results
demonstrate its potential benefit as an IBS treatment
modality. A recent animal study by Zhang et al. [14] rec-
ognized methylglyoxal as an important cause of IBS
symptoms. This bacterial product of anaerobic glycolysis
in the large intestine elicits symptoms such as arrhythmia,
headache, and diarrhea. Activation of NMDA receptors by
methylglyoxol promotes visceral hypersensitivity, resulting
23 IBS paents parcipated
in the inial screening 
5 paents were excluded (did 
not ﬁt the inclusion criteria) 
IBS-D group: 6 paents IBS-C group: 12 paents
1C: 3, 2C: 3, 3C: 3, 4C: 31D: 1, 2D: 1, 3D: 2, 4D: 2
2 paents were excluded:
1 withdrew from study
1 diagnosed with cervical cancer
Another 2 were screened for 
substuon of the missing paents 
Fulﬁlled IBS-C 
criteria 
1C: 3, 2C: 3, 3C: 3, 4C: 3 
Randomizaon Randomizaon 
Fig. 2 Schematic flow chart from screening to randomization of participants
Table 1 Demographics of study participants
Group All IBS-C IBS-D
Sex
Male 5 (28 %) 1 (8.3 %) 4 (67 %)
Female 13 (72 %) 11 (91.7 %) 2 (33 %)
Age (years)
Mean ± SD 45.2 ± 13.6 44.7 ± 15.1 46.0 ± 11.2
Range 24–62 24–62 31–58
IBS-C constipation-dominant irritable bowel syndrome, IBS-D diar-
rhea-dominant irritable bowel syndrome, SD standard deviation
554 Tech Coloproctol (2016) 20:551–557
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in increased 5HT secretion and peristalsis contributing to
diarrhea. Visceral hypersensitivity reduces the threshold to
noxious stimuli and bowel distension, providing a reason-
able explanation for abdominal pain [15, 16], the major
feature of IBS. We deduced that methylglyoxol and per-
haps other metabolites could be washed out by water irri-
gation, and reverse visceral hypersensitivity. Zhang’s study
may serve to renew interest in the concept ‘‘body detoxi-
fication’’ by colonic irrigation, which is at present not well
accepted by the medical professions [17].
Almost all participants with IBS-C experienced more
than one additional BM per week than before treatment.
Colonic irrigation also improved the stool consistency in
most participants, whether this was for hard, lumpy stool in
IBS-C or loose, watery stool in IBS-D patients. The results
demonstrate colonic irrigation is effective in improving
IBS-related constipation and diarrhea.
The influence of treatment duration on efficacy was
investigated by dividing the treatment into 1- to 4-week
courses. Abdominal pain, satisfaction with BM, and
distress/discomfort due to symptoms were improved after
initiation of colonic irrigation. This improvement was
maintained throughout the treatment phase and even up to
the post-treatment phase in every subgroup (data not
shown). The treatment effects seemed to be independent of
the treatment duration, but our short-term data are not
adequate to support this conclusion.
Safety is always the greatest concern with bowel irri-
gation therapy, and rectal perforations and sepsis are not
uncommon. Such complications have been attributed to
malpractice by patients and non-medical personnel [18–
21]. However, the estimated rate of bowel perforation
resulting from transanal irrigation is low, with a reported
rate of\0.002 % [5, 7]. A well-devised treatment protocol
used by experienced practitioners might reduce the risk of
bowel perforation [20, 21]. Conversely, undiscovered
conditions such as stercoral ulcer [19] or tumors could
increase the risk of perforation. In this study, we provided
complete colonic evaluations and detailed instructions for
the treatment. Our patients experienced only mild adverse
Fig. 3 a Scores of abdominal pain, satisfaction, and degree of
distress/discomfort due to symptoms before and after treatment.
Calculations involved all constipation-dominant irritable bowel
syndrome and diarrhea-dominant irritable bowel syndrome patients.
b Frequency of bowel movements before and after treatment. c Stool
consistency changes in response to colonic irrigation
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events such as sensation of abdominal fullness, weakness,
and anal pain which did not necessitate either discontinu-
ation of treatment or medical intervention.
A series of 36 cases of amebiasis cross-infection with 10
colectomies, in which 6 patients at a chiropractic clinic in
Western Colorado died, was previously reported [22]. The
outbreak led to the use of disposable, single-use parts of
colonic irrigation devices [18], and patient-specific colonic
irrigation system for defecation disorders are necessary to
prevent cross-contamination.
Eight liters of water was required for a complete 1-day
treatment, and water intoxication is an important safety
concern in colonic irrigation. However, no neurological
symptoms or altered serum biochemistry parameters, such
as hyponatremia were observed in this study. In addition,
since patients were allowed to defecate at any time during
irrigation, the amount of water absorption via the colonic
mucosa was very small. Lower than normal limit basal
serum GOT, GPT, cGT, and BUN levels were observed in
about 45 % of the participants, suggesting these could be
clinical signs of IBS. Moreover, colonic irrigation did not
cause impairment in blood serum biochemistry or elec-
trolyte imbalance. Chronic consumption of alcohol
appeared to account for the only candidate with impaired
basal and post-treatment GOT and GPT levels. Sacral
nerve stimulation and the Malone antegrade continence
enema procedure have been shown to be effective in
patients with unremitting constipation and defecation dis-
orders, improving QoL [23–26]. However, those are inva-
sive procedures that come with a risk of surgical
complications. Rectal or colonic irrigation is considered to
be less invasive and effective as well [7, 8]. Irrigation
treatment should be considered as the treatment of choice
prior to surgical interventions [4, 13]. The concept behind
ACIA is no different from that behind the ordinary colonic
irrigation sets [4, 7–9], but ACIA is simpler and more
convenient.
Our results demonstrated that colonic irrigation with
ACIA can be effective for IBS treatment. The improvement
of abdominal pain, satisfaction with BM, and distress/dis-
comfort due to symptoms indicated there was good relief of
IBS-related problems and the patients were satisfied with
the treatment. However, a placebo effect [27] should be
taken into consideration. The positive effects on BM fre-
quency and stool consistency are encouraging, and those
are objectively measurable. QoL is always an important
parameter for the effectiveness evaluation of IBS treat-
ment. In this study, we focused on the feasibility of colonic
irrigation on IBS treatment and QoL evaluation is therefore
lacking.
The limitations of this study are the small sample size
and short follow-up time.
Conclusions
The Ashong colonic irrigation apparatus is a simple, safe
device that allows for patient self-administration of colonic
irrigation. Our pilot study showed colonic irrigation can be
effective in improving the abdominal pain, constipation,
and diarrhea associated with IBS. However, the impact of
placebo should be considered and is worth investigation.
Larger studies with long-term follow-up are needed in
order to draw more reliable conclusions.
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